Skip to content

Vegetables Intake and Polymorphism TAS2R38 Gene by Healthy Adults

Can Including Genotype Information Increase the Effectiveness of Dietary Interventions? Vegetables Intake and Polymorphism TAS2R38 Gene by Healthy Adults

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04145453
Enrollment
174
Registered
2019-10-30
Start date
2019-10-01
Completion date
2022-02-17
Last updated
2022-07-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diet Habit, Healthy Lifestyle, Taste Disorders

Keywords

TAS2R38 Polymorphism, bitter, taste, PAV, AVI, vegetables, personalized nutrition, genotype, intake, fruit and vegetables

Brief summary

Personalized nutrition is one of the most up to date trends in human nutrition and gains much interest of general public and scientists as well. Although we have gained some knowledge on gene-trait associations, the real effectiveness and usefulness of genotype-based nutritional recommendations is unknown. Many personalized nutrition companies are on the market today, some of them use personalized nutrition based on genotype analysis. For this reason, scientific basis of this approach should be clarified. Our project can thus increase knowledge which can be applied in dietary counseling practice. Although we focus on increase vegetable and fruits intake, the study is designed as a proof of concept.

Detailed description

In humans, the TAS2R38 receptor gene is responsible for differences in the perception of bitter taste. This gene codes for a G protein that is associated with a flavor receptor regulated by phenylthiocarbamide (PTC) and propylthiouracil (PROP) ligands, which by binding to the receptor determines the degree of bitter taste. Cruciferous vegetables contain glucosinolates and isothiocyanates, which resemble PTC and PROP and thereby affect their perception of bitter taste through the TAS2R38 regulated receptor. The polymorphism of this gene allows to distinguish three phenotypes: * insensitive to bitter taste \[bitter-non tasters\] * moderately sensitive to bitter taste \[intermediate-bitter tasters\] * sensitive to bitter taste \[bitter taster\] Previous studies have shown that people who are carriers of one PAV haplotype experience a bitter taste more than AVI / AVI homozygotes, which are less sensitive to bitter taste. Hence, the TAS2R38 gene polymorphism is associated with nutritional decisions, including choice of vegetables and coffee. Aim of the study is to verify effectiveness of the genotype based dietary intervention in people with or without polymorphism of TAS2R38 gene.

Interventions

BEHAVIORALIntervention genotype personalized nutritional recommendations

Participants will receive personalized nutritional recommendations to increase fruit and vegetables consumption. Information about genotype will be given at the beginning of study

BEHAVIORALControl Group 1 personalized nutritional recommendations

Participants will receive genotype personalized nutritional recommendations to increase fruit and vegetables consumption. Information about genotype will be given at the end of study

BEHAVIORALControl Group 2 general nutritional recommendations

Participants will receive general nutritional recommendations to increase fruit and vegetables consumption

Sponsors

Poznan University of Life Sciences
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
BASIC_SCIENCE
Masking
SINGLE (Investigator)

Masking description

lnvestigator is responsible for collecting the questionnaires and anonymizing the data

Intervention model description

To achieve the goals of the study, a group of healthy adults will be qualified. Genotype will be assed at the baseline. Consumption of fruit and vegetables will be assessed before and after intervention. The duration of the study will be 20 weeks. Blood results and body analyze will be assessed at the beginning and after the intervention. Overall food consumption will be assessed at the beginning. For the basic characteristics of study participants, their anthropometric and biochemical parameters will be analyzed twice at the baseline and after intervention. The intervention effect, including the TAS2R38 polymorphism, will be analyzed by statistical analysis. In a randomized manner volunteers will be assigned to one of three groups: intervention and two control group.

Eligibility

Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
Yes

Inclusion criteria

* healthy

Exclusion criteria

* injuries, chronic diseases (e.g. diabetes, metabolic syndrome, cancer, hyperthyroidism), recent diet, pregnancy, breastfeeding, limited communication to the extent that no nutritional history can be carried out, eating disorders (according to nutritional history)

Design outcomes

Primary

MeasureTime frameDescription
Vegetables intakeBaseline, 20 weeksChange in frequency of vegatables intake within the group and between the groups; Block vegetables intake screener
TAS2R38 polymorphismbaselinegenotyping of polymorphism TAS2R38 gene (rsr713598, rs1726866, and rs10246939)

Secondary

MeasureTime frameDescription
Fat Mass (FM) %Baseline, 20 weekschange in Fat Mass % within the group and between the groups
Waist circumference (WC)Baseline, 20 weeksChange in WC (cm) within the group and between the groups
Total Cholesterol (TChol)Baseline, 20 weeksChanges in TChol (mg/dl) within the group and between the groups
LDL Cholesterol(LDL-Chol)Baseline, 20 weeksChanges in LDL-Chol (mg/dl) within the group and between the groups
HDL Cholesterol (HDL-Chol)Baseline, 20 weeksChanges in HDL-Chol (mg/dl) within the group and between the groups
Body Mass (BM)Baseline, 20 weekschange in body mass (kg) within the group and between the groups
Glucose (GLU)Baseline, 20 weeksChanges in GLU (mg/dl) within the group and between the groups
Insulin (INS)Baseline, 20 weeksChanges in INS (ulU/ml) within the group and between the groups
Alanine transaminase (ALAT)Baseline, 20 weeksChanges in ALAT (U/l) within the group and between the groups
aspartate aminotransferase (ASPAT)Baseline, 20 weeksChanges in ASPAT (U/l) within the group and between the groups
Triglycerides (TG)Baseline, 20 weekChanges in TG (mg/dl) within groups and between groups
Fat free mass (FFM)Baseline, 20 weekschange in FFM (kg) within the group and between the groups

Countries

Poland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026